MVP and MID2

  • Number of citations of the paper that reports this interaction (PMID 24722188)
  • 1
  • Data Source:
  • BioGRID (two hybrid)

MVP

MID2

Gene Name major vault protein midline 2
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 57 interactors: ADAMTSL4 AES BANP BZRAP1 C1orf94 CALCOCO2 CAMK2B CCDC36 CKAP4 CYTB DISC1 DLX2 EPHX2 ESR1 FAM154A FAM46C GIT2 GOLGA2 HP KCTD9 KPNA2 KPNA3 MDFI MEOX1 MEOX2 MID2 MKL1 NNT NOTCH2NL OBFC1 PARP4 PIH1D2 PLSCR1 POT1 PSTPIP1 PTEN PTPN11 RAB3IP RBPMS REL RHOXF2 RIMBP3 RNF111 SERTAD1 SKIL SLC2A4 TCF4 TFCP2 TP53 TRAF2 TRIM27 TRIM42 TRIP13 TRIP6 VAC14 ZBTB32 ZMIZ2 108 interactors: ADAMTSL4 AEN AQP1 ATRIP BCL6B BRCA1 BRMS1L BYSL C19orf66 CALCOCO2 CBX8 CCDC120 CCDC42 CCHCR1 CEP57L1 CHD2 CTSZ DCX DGCR6 DGCR6L DIEXF DMRT3 DYDC1 FAM107A FAM161A FAM214A FAM90A1 FARS2 FBF1 FBXL18 FRMD6 GFI1B GMCL1 GOLGA2 GORASP2 HOXB9 IGBP1 ISCU JOSD1 KIAA1683 KIF1A KIFC3 LENG1 LGALS14 LGALS8 MAGOHB METTL17 MFAP1 MID1 MID1IP1 MOS MVP NR1D2 NXF1 OTUB2 PPP1R18 PRPF31 PSMA1 PTCD2 RCOR3 RPH3AL RPP25L RUNX1T1 SCNM1 SDCBP SLC25A48 SLC25A6 SNAI1 SNAP47 SPATA24 SPG21 SPRY2 STX11 SYT17 TCEA2 TCEB3 THAP7 TOP3B TRIM27 TRIM29 TRIM32 TRIM42 TRIM54 TRPV6 TSGA10 UBE2D1 UBE2D4 UBE2E2 UBE2E3 UBE2U UBTD1 UNC45A UTP23 WT1-AS ZBTB24 ZC2HC1C ZFYVE21 ZGPAT ZNF165 ZNF24 ZNF250 ZNF417 ZNF440 ZNF564 ZNF587 ZNF785 ZNF792 ZSCAN12
Entrez ID 9961 11043
HPRD ID 05475 02191
Ensembl ID ENSG00000013364
Uniprot IDs B4DP93 Q14764 Q9UJV3
PDB IDs 1Y7X 2DJA 2DMK
Enriched GO Terms of Interacting Partners?
Tagcloud ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
Tagcloud (Difference) ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
Tagcloud (Intersection) ?